Description
Recombinant Human Long Insulin-Like Growth Factor II is produced by our E.coli expression system and the target gene encoding Ala25-Glu91 is expressed.
Product Details
| Item | Details |
| Known As | Insulin-Like Growth Factor II; IGF-II; Somatomedin-A; IGF2; PP1446 |
| Mol Mass | 8.91 KDa |
| APMol Mass | 11 KDa, reducing conditions |
| Formulation Description | Lyophilized from a 0.2 μm filtered solution of 20mM Glycine-HCl, 4% Sucrose, 4% Mannitol, 0.02% Tween 80 (w/v), pH3.0. |
| Endotoxin | < 1 EU/µg as determined by LAL test. |
| Reconstitution | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| Storage | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
Background
Insulin-Like Growth Factor II (IGF2) belongs to the insulin family of polypeptide growth factors that is involved in development and growth. Members of this family are structurally homologous to proinsulin, and share higher sequence identity. IGF2 is expressed only from the paternally inherited allele and believed to be secreted by the liver and to circulate in the blood. IGF2 possess growth-promoting activity and can stimulate the proliferation and survival of various cell types including muscle, bone, and cartilage tissue in vitro. IGF2 is influenced by placental lactogen and may play a role in fetal development.
title: 3D Printed HA/β-TCP Scaffold: A Macroscopic Microscopic Analysis and Biological Validation Study of the Effect of the Component Ratio on Performance
authors: Zhitao Yin, Yutong Chen, Guang Yang, Shuaishuai Wang, Bingbing Wang, Kefeng Wang, Shun Zhang, Xujing Zhang, Yanen Wang, Yan Xu
date: 2025/10/14
journal: ACS Applied Bio Materials
title: PLAGL1-IGF2 axis regulates osteogenesis of postnatal condyle development
authors: Sun Jinrui, Xu Jingyi, Xu Yue, Liu Yili, Yao Enhui, Du Jiahui, Jiang Xinquan
date: 2025/09/25
journal: International Journal of Oral Science
title: Insulin‐Like Growth Factor 2 Reverses Synaptic and Cognitive Deficits in Fetal Growth Restriction Mice
authors: Jianfeng Dong, Wen Chen, Shujuan Chang, Nana Liu, Wei Zhu, Li Ma, Jing Qiao, Yuhang Wang, Zhiyong Mao, Jiuhong Kang
date: 2025/06/03
journal: FASEB JOURNAL
title: KH571 construct interfacial molecular bridge in calcium silicate/TMPTA/HDDA scaffolds for improving mechanical properties, biodegradability and photopolymerization
authors: Yutong Chen, Zhitao Yin, Yue Zhao, Zhengyang Jin, Seeram Ramakrishna, Yan Xu, Xujing Zhang
date: 2024/11/02
journal: CHEMICAL ENGINEERING JOURNAL
title: RNA-Binding Protein IGF2BP2/IMP2 is a Critical Maternal Activator in Early Zygotic Genome Activation
authors: Hong-Bin Liu, Tahir Muhammad, Yueshuai Guo, Meng-Jing Li, Qian-Qian Sha, Chuan-Xin Zhang, Hui Liu, Shi-Gang Zhao, Han Zhao, Hao Zhang, Yan-Zhi Du, Kang Sun, Kui Liu, Gang Lu, Xue-Jiang Guo, Jiahao Sha, Heng-Yu Fan, Fei Gao, Zi-Jiang Chen
date: 2019
journal: Advanced Science
title: Regulation of chitosan-mediated differentiation of human olfactory receptor neurons by insulin-like growth factor binding protein-2
authors: Tsung-Wei Huang, Sheng-Tien Li, Yu-Hsin Wang, Tai-Horng Young
date: 2019
journal: Acta Biomaterialia
MDSD